Themis Medicare Ltd Share Price – NSE /  BSE

Pharmaceuticals, Small Cap

Net profit of Themis Medicare reported to Rs 8.89 crore in the quarter ended March 2026 as against net loss of Rs 9.66 crore during the previous quarter ended March 2025. Sales rose 6.74% to Rs 76.53 crore in the quarter ended March 2026 as against Rs 71.70 crore during the previous quarter ended March 2025.

For the full year,net profit declined 96.18% to Rs 1.14 crore in the year ended March 2026 as against Rs 29.83 crore during the previous year ended March 2025. Sales declined 15.60% to Rs 342.24 crore in the year ended March 2026 as against Rs 405.51 crore during the previous year ended March 2025.

Powered by Capital Market - Live News

Themis Medicare announced that the Board of Directors of the Company at its meeting held on 28 May 2026, inter alia, have recommended the final dividend of Rs 0.5 per equity Share (i.e. 50%) , subject to the approval of the shareholders.

Themis Medicare will hold a meeting of the Board of Directors of the Company on 28 May 2026.

Themis Medicare will hold a meeting of the Board of Directors of the Company on 13 February 2026.

Powered by Capital Market - Live News